FDA chief Gottlieb resigning

The Department of Health and Human Services said that the FDA chief Scott Gottlieb announced his planned resignation, and plans to step down in one month. Gottlieb won bipartisan support for his efforts to curb the use of flavored e-cigarettes by youths, speed approval times for cheap generic medicines to increase competition and bring down prescription drug prices and boost the use of cheaper versions of expensive biotech medicines, called biosimilars. Health and Human Services (HHS) Secretary Alex Azar said in a statement that "Scott's leadership inspired historic results which delivered record approvals of both innovative treatments and affordable generic drugs while advancing important policies to confront opioid addiction, tobacco, and youth e-cigarette use,” @ https://www.reuters.com/article/us-usa-fda-gottlieb/fda-chief-gottlieb-resigning-idUSKCN1QM2GZ?feedType=RSS&feedName=newsOne